These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12353058)

  • 1. LY404187: a novel positive allosteric modulator of AMPA receptors.
    Quirk JC; Nisenbaum ES
    CNS Drug Rev; 2002; 8(3):255-82. PubMed ID: 12353058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.
    Miu P; Jarvie KR; Radhakrishnan V; Gates MR; Ogden A; Ornstein PL; Zarrinmayeh H; Ho K; Peters D; Grabell J; Gupta A; Zimmerman DM; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):976-83. PubMed ID: 11406188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro.
    Gates M; Ogden A; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):984-91. PubMed ID: 11406189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptor potentiators: application for depression and Parkinson's disease.
    O'Neill MJ; Witkin JM
    Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo.
    Vandergriff J; Huff K; Bond A; Lodge D
    Neuropharmacology; 2001 Jun; 40(8):1003-9. PubMed ID: 11406191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons.
    Baumbarger P; Muhlhauser M; Yang CR; Nisenbaum ES
    Neuropharmacology; 2001 Jun; 40(8):992-1002. PubMed ID: 11406190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of neurite growth with AMPA receptor potentiation.
    Voss OP; Milne S; Sharkey J; O'Neill MJ; McCulloch J
    Neuropharmacology; 2007 Feb; 52(2):590-7. PubMed ID: 17101156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat.
    Fowler JH; Whalley K; Murray T; O'neill MJ; McCulloch J
    J Cereb Blood Flow Metab; 2004 Oct; 24(10):1098-109. PubMed ID: 15529010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
    O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
    Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ampakine treatment ameliorates age-related deficits in long-term potentiation.
    Radin DP; Zhong S; Purcell R; Lippa A
    Biomed Pharmacother; 2016 Dec; 84():806-809. PubMed ID: 27721179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY404187, a potentiator of AMPARs, enhances both the amplitude and 1/CV2 of AMPA EPSCs but not NMDA EPSCs at CA3-CA1 synapses in the hippocampus of neonatal rats.
    Song B; Lee S; Choi S
    Neurosci Lett; 2012 Dec; 531(2):193-7. PubMed ID: 23103715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging.
    Jones N; O'Neill MJ; Tricklebank M; Libri V; Williams SC
    Psychopharmacology (Berl); 2005 Aug; 180(4):743-51. PubMed ID: 15864556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
    Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
    Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice.
    Giralt A; Gómez-Climent MÁ; Alcalá R; Bretin S; Bertrand D; María Delgado-García J; Pérez-Navarro E; Alberch J; Gruart A
    Neuropharmacology; 2017 Sep; 123():395-409. PubMed ID: 28603025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.
    Nagarajan N; Quast C; Boxall AR; Shahid M; Rosenmund C
    Neuropharmacology; 2001 Nov; 41(6):650-63. PubMed ID: 11640919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
    Roberts BM; Holden DE; Shaffer CL; Seymour PA; Menniti FS; Schmidt CJ; Williams GV; Castner SA
    Behav Brain Res; 2010 Sep; 212(1):41-8. PubMed ID: 20347881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.